PD patient-derived fibroblast lines harboring a LRRK2 mutation (G2019S) had significantly more Parkin rings (p < 0.05), compared to healthy subject controls and the other PD patient-derived fibroblast lines (Fig. 4e). Here, PRKN is linked to Parkinson disease.